Tue 28th Jul 15, 14:08:04
(ShareCast News) - With a potential bid now on the cards, Canaccord Genuity raised its rating on RSA Insurance to 'buy' from 'sell' and upped the target price to 500p from 385p, which is a 10% discount to the offer price that's been talked about.
Search news for stories that mention a company:
Show only the stories that interest you with news filter.
(ShareCast News) - Another slide in Chinese stocks sparked a wave of risk aversion that swept across all asset classes on Monday. less than a minute ago
(ShareCast News) - Investors were hedging their bets ahead of the start of a two-day policy meeting from the US Federal Reserve, with some observers expecting the post-meeting statement to be tweaked should Chair Janet Yellen be intending to start a cycle of policy tightening come September. 1 hour ago
(ShareCast News) - Convenience store business McColl's Retail boosted pre-tax profits to £7.6m from a loss of £4m for the same period last year. 2 hours ago
(ShareCast News) - Mining sector-focused group Leed Resources said it has reached an agreement to invest a further AU$480,000 (£225,000) in Battallion International Limited. 2 hours ago
(ShareCast News) - RyanAir's shares fell 2.25% after it posted its first quarter results, partly because management voiced concerns over fuel prices, the Financial Times' Lex writes. 2 hours ago
(ShareCast News) - Credit Suisse upgraded Bwin.party Digital Entertainment to 'neutral' from 'underperform' and raised the price target to 110p from 80p, saying it's now very likely a deal will take place with 888 Holdings. 2 hours ago
Disclaimer: This news feed is provided by Digital Look Ltd. BullBearings Ltd do not necessarily share the views expressed within the stories. The stories are for general information purposes only and not a solicitation or personal reccomendation to deal. BullBearings Ltd accepts no liability or responsibility for any of the content contained in the information provided by Digital Look Ltd.
Just before the dawn of 2015, Bullbearings gathered together eight trading experts (plus me) to select some stock tips and top trades for 2015. This is a half-time report, with a top-10 leadboard and each tipster giving an update on their chosen recommendation.
Safe to say, I'm propping up the table and making the rest of them look good - but as I said at the time, picking one share to buy is a notoriously difficult thing to do - especially if you take a speculative punt on a small cap. It's been an unusual year and there's still five months to go...
Nasstar (NASA), which I highlighted at 8.5p at the end of last year, had made good progress in its first 18 months as a quoted company but the loss of a major customer will have a negative effect on the second half of 2015.
The news, in a recent trading statement, is bad news for the current financial year and the performance of the share price in 2015 but the underlying attractions of the cloud-based IT services and hosting provider remain.
You may have a stellar portfolio; it might seem as if every trade is going your way lately, but there is one critical factor that is often overlooked by traders and desk jockeys alike.
Both quantity and quality of sleep tend to be neglected by many people in our modern age, leading to an increased risk of countless health conditions, ranging from weight gain and inflammation, to a compromised immune system and even a greater risk of cancer.
In the wake of the Greek crisis of June, the UK banking sector rallied, but it now looks as if the bounce has run its course.
It has been a see-saw year for the sector, but from a technical perspective the immediate path looks to be downward.
Trading expectancy is not a subject that often comes up in the average book on trading. Guides that don't cover trading expectancy will focus mainly on trade selection and timing, and in the end readers will lose money. But author Dirk Vandycke uses it to increase his win ratio.
Even books that cover trading expectancy often get it wrong. Either they understate its importance, which almost makes them a match for the books that don't mention it, or more often still they can even teach a totally wrong way of looking at expectancy, taking yet another step in the wrong direction. In this article, we will aim to fix that problem once and for all.